Cargando…
A Review of the Clinical Implications of Cachexia, Sarcopenia, and BMI in Patients with Peritoneal Carcinomatosis Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
SIMPLE SUMMARY: Patients with peritoneal carcinomatosis from varying cancers may be affected by weight loss and decreased muscle mass, the hallmarks of cachexia. These patients can undergo surgical management via cytoreductive surgery and hyperthermic intraperitoneal chemotherapy to improve their ov...
Autores principales: | Freudenberger, Devon C., Vudatha, Vignesh, Riner, Andrea N., Herremans, Kelly M., Fernandez, Leopoldo J., Trevino, Jose G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221457/ https://www.ncbi.nlm.nih.gov/pubmed/35740519 http://dx.doi.org/10.3390/cancers14122853 |
Ejemplares similares
-
Racial Disparities in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Aggressive Surgical Treatment Overcome Cancer Health Inequities?
por: Freudenberger, Devon C., et al.
Publicado: (2022) -
Race and Ethnicity Impacts Overall Survival of Patients with Appendiceal Cancer Who Undergo Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Freudenberger, Devon C., et al.
Publicado: (2023) -
Review of Mechanisms and Treatment of Cancer-Induced Cardiac Cachexia
por: Vudatha, Vignesh, et al.
Publicado: (2022) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)